Recent Finacing
Recent Raise
Oncgnostics is a Jena-based diagnostics company that develops in vitro molecular tests using proprietary epigenetic biomarkers, including GynTect, a rapid swab assay for cervical precancer and cancer detection.
Focus Areas
Recent Investors
Funding rounds
Investors
See the team members at Oncgnostics.